Dr Joseph S Higgins Jr, PHARMD | |
2702 Calumet Dr, Sheboygan, WI 53083-3835 | |
(920) 457-5656 | |
(920) 457-1731 |
Full Name | Dr Joseph S Higgins Jr |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2702 Calumet Dr, Sheboygan, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144853763 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 19783-40 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joseph S Higgins Jr, PHARMD 2702 Calumet Dr, Sheboygan, WI 53083-3835 Ph: (920) 457-5656 | Dr Joseph S Higgins Jr, PHARMD 2702 Calumet Dr, Sheboygan, WI 53083-3835 Ph: (920) 457-5656 |
News Archive
Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.
Researchers from France and the U.S. demonstrated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could induce an early and vigorous virus-specific IgA response that paves the way for the production of SARS-CoV-2 IgG antibodies, with even better neutralizing properties. Their paper is currently available on the medRxiv preprint server.
RXi Pharmaceuticals Corporation today announced that it successfully initiated its first ever clinical study with an RNAi compound, RXI-109, using their proprietary self-delivering RNAi technology.
"More than 50 percent of all new cancers and two-thirds of the annual cancer mortality worldwide happen in low-income and middle-income countries," a Lancet editorial states and describes how the recently released report Closing the Cancer Divide, by the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, "presents a compelling case for comprehensive action on expanded access to cancer care and control with realistic recommendations that will be beneficial beyond cancer."
› Verified 3 days ago
Mr. Lawrence J Mihalevich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 | |
Mary Miller, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1317 N 25th St, Picknsave Pharmacy 6432, Sheboygan, WI 53081 Phone: 920-457-5839 Fax: 920-457-5853 | |
Christa Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 Saemann Ave, Sheboygan, WI 53081 Phone: 920-783-6633 | |
Judith L Lukach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Matthew Wilke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3529 Superior Ave, Sheboygan, WI 53081 Phone: 920-459-2755 | |
Dr. David Roth, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 N 14th St, Sheboygan, WI 53081 Phone: 920-452-0079 | |
Tou Lee Xiong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1029 N 14th St, Sheboygan, WI 53081 Phone: 920-458-7707 |